FOR IMMEDIATE RELEASE
New Features and System Enhancements Incorporated into Leading EDC Solution Further
Increase Performance and User Productivity for Sites and Sponsors
NEW YORK, NY – January 29, 2008 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced the introduction of Medidata Rave 5.6.2 (http://www.mdsol.com/products/rave_overview.htm ). With this version, Medidata has incorporated its eLearning module directly into the Rave system, allowing sponsors to empower investigator sites to quickly and easily become trained on Rave, speeding study start-up and patient data gathering. In addition to its eLearning capabilities, Medidata Rave 5.6.2 comes with a range of tools that offer sponsors new ways to increase productivity and enhance the research experience for the clinical study team.
Since its inception, Medidata Rave was designed for maximum ease of use and, as a result, training for users at sites and sponsors has remained quick and simple. By incorporating Medidata’s existing eLearning (http://www.mdsol.com/services/elearning.htm ) capabilities into the Rave system, Medidata now provides rapid and targeted user training directly within the familiar Rave interface. With instant access 24/7 worldwide on any Web-enabled computer, sites and sponsors benefit from the following eLearning features:
Sites
Customized, on-demand and self-paced training courses for ease of use;
Immediate and seamless access to the study once automated training is completed, enabling faster trial start and data collection;
Instant, downloadable and printable certification available to investigators and sponsors.
Sponsors
Secure log-in to eLearning without additional administrative steps;
Easy and fast deployment and delivery of training for all Rave users;
Web-based, simple training for time, task and cost savings.
“As Medidata Rave continues to play an increasingly important role in our clinical trial functions, it has been critical for us to establish an efficient training program, especially with some of our largest studies where we have to bring multiple investigators and sites up to speed,” said Louise Archer, Data Management Technology Process Manager at AstraZeneca (www.astrazeneca.com ). “Medidata Rave’s enhanced eLearning tool will provide us with customizable, easy and fast training and user education directly within the Medidata Rave system, ultimately leading to better trained investigators, faster study starts and higher cost savings.”
Beyond eLearning: Rave 5.6.2 New Features and Enhancements
In addition to its eLearning functionality, Medidata Rave 5.6.2 provides further productivity and efficiency for the clinical study team through enhancements and additions to the industryleading Rave 5.6 platform. The experience of users – from site personnel and monitors to managers and data administrators as well as study builders at sponsors who build their own trials – has been upgraded with:
Configurable Welcome Message: Allowing study managers to display appropriate customized messages which can be targeted to a specific study and/or role and translated into multiple languages on the home page;
Publish-in-Place: Speeding the study build process by allowing immediate updating of CRF versions during development;
Custom Function Development Utility: Assisting study builders in development and testing of custom edit checks building complex data queries;
User Loader: Allowing user administrators to speed the enrollment and maintenance of user information by uploading or downloading files;
Performance Enhancements: Providing improved page refresh performance and a host of other system enhancements that significantly upgrades system speed for all users.
“Our customers – global pharmaceutical and medical device companies, biotechs, CROs and academic and government institutions – continue to rely on Medidata Rave as the central tool for their global clinical trial information collection, management and reporting,” said Glen de Vries, CTO of Medidata Solutions. “In version 5.6.2, we designed a host of enhancements and additions that will significantly benefit all the functions in the clinical trial process – from investigators and coordinators at the site level to data managers and user administrators to study builders.”
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data – the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market – on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit
www.mdsol.com.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com